Scabies Treatment Market 2026

November 2025 | 223 pages | ID: S5D0D70D4EBCEN
DataM Intelligence

Abstracts

The Scabies Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Scabies Treatment Market.

This report delivers a comprehensive overview of the Scabies Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Scabies Treatment Market. The Scabies Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

Scabies Treatment Market Scope:

By Type

• Typical Scabies
• Nodular Scabies
• Contagious or Norwegian scabies

By Treatment Type

• Topical Agents
• Oral Agents
• Others

By Route of Administration

• Topical
• Oral
• Intravenous

By Distribution Channel

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Key Players

• HH Pharma
• Merck & CO., Inc.
• Trio Lifescience Private Limited.
• Incepta Pharmaceuticals Ltd.
• PalsonsDerma
• Abbott Laboratories
• NuLife Pharmaceuticals
• Teva Pharmaceutical Industries Ltd
• Amneal Pharmaceuticals LLC
• Aurobindo Pharma

Major Highlights

This report delivers a comprehensive overview of the Scabies Treatment Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Scabies Treatment Market. The Scabies Treatment Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

3.1. Snippet by Type
3.2. Snippet by Treatment Type
3.3. Snippet by Route of Administration
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. DYNAMICS

4.1. Impacting Factors
  4.1.1. Drivers
    4.1.1.1. Increasing Demand for Innovative Therapeutics
    4.1.1.2. Rising Awareness and Early Detection
  4.1.2. Restraints
    4.1.2.1. Side Effects Associated with Therapeutics
  4.1.3. Opportunity
    4.1.3.1. Technological Advancements in Treatment Options
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of COVID-19
  6.1.1. Scenario Before COVID-19
  6.1.2. Scenario During COVID-19
  6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type
7.2. Typical Scabies *
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Nodular Scabies
7.4. Contagious or Norwegian scabies

8. BY TREATMENT TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  8.1.2. Market Attractiveness Index, By Treatment Type
8.2. Topical Agents *
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  8.2.3. Permethrin cream
  8.2.4. Crotamiton lotion and Crotamiton cream
  8.2.5. Sulfur ointments
  8.2.6. Lindane lotion
  8.2.7. Benzyl benzoate (with or without tea tree oil)
  8.2.8. Others
8.3. Oral Agents
  8.3.1. Ivermectin
8.4. Others

9. BY ROUTE OF ADMINISTRATION

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
  9.1.2. Market Attractiveness Index, By Route of Administration
9.2. Topical *
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Oral
9.4. Intravenous

10. BY DISTRIBUTION CHANNEL

10.1. Introduction
  10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Hospital Pharmacies *
  10.2.1. Introduction
  10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Online Pharmacies
10.4. Retail Pharmacies

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
  11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
  11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. U.K.
    11.3.7.3. France
    11.3.7.4. Spain
    11.3.7.5. Italy
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
  11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia-Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
  11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. Australia
    11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type
  11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Route of Administration
  11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. COMPETITIVE LANDSCAPE

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. COMPANY PROFILES

13.1. HH Pharma *
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Financial Overview
  13.1.4. Key Developments
13.2. Merck & CO., Inc.
13.3. Trio Lifescience Private Limited.
13.4. Incepta Pharmaceuticals Ltd.
13.5. PalsonsDerma
13.6. Abbott Laboratories
13.7. NuLife Pharmaceuticals
13.8. Teva Pharmaceutical Industries Ltd
13.9. Amneal Pharmaceuticals LLC
13.10. Aurobindo Pharma (*LIST NOT EXHAUSTIVE)

14. APPENDIX

14.1. About Us and Services
14.2. Contact Us